Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Alzheimer’s Expert Jams with Aerosmith

June 26, 2015 8:59 am | by Bevin Fletcher, Associate Editor | News | Comments

One of the world’s leading Alzheimer’s researchers doubles as a guest organist for Aerosmith. Rudy Tanzi, Ph.D., the Kennedy professor of neuroscience at Harvard, hit it off with lead guitarist Joe Perry on a photo shoot for men’s fashion magazine GQ, and the scientist, who is an expert on how beta amyloid accumulates in the brain, has since played with the band on a number of special occasions, CNN reported. Read more...


Human Trials of Manufactured Blood within Two Years

June 26, 2015 8:34 am | by University of Bristol | News | Comments

The clinical trial of manufactured red blood cells is designed to compare the survival of red cells manufactured from stem cells with that of standard blood donor red blood cells. Read more...


French Senators Reject Bill on Sedating Terminal Patients

June 26, 2015 8:34 am | by The Associated Press | News | Comments

Senators in Paris rejected the law by a vote of 196-87. Read more...


Cancer Drug Makes Fruit Flies Live Longer

June 26, 2015 8:33 am | by University College London | News | Comments

The drug targets a specific cellular process that occurs in animals, including humans, delaying the onset of age-related deaths by slowing the ageing process. Read more...


Melatonin Offers Hope for ADHD Bedtime Shut-Eye

June 26, 2015 8:32 am | by University of Queensland | News | Comments

Researchers are recruiting trial participants for a study investigating the effectiveness of the natural hormone melatonin on children with ADHD who are struggling to settle at bedtime. Read more...


Breast Cancer Paper to Be Retracted– 3 Years After False Data Exposed

June 26, 2015 8:31 am | by Seth Augenstein, Digital Reporter | News | Comments

An academic paper that outlined how breast cancer molecules metastasize will be retracted next week, because of falsified data. Read more...


Global Gene Therapy Deals Sky-Rocketed to Nearly $5B in 2014

June 26, 2015 8:31 am | by Adam Dion, MS, Senior Industry Analyst, GlobalData | Articles | Comments

Nearly $1.5 billion was raised in the gene therapy arena from 2014 to 2015. Read more...


Eli Lilly Wins U.K. Alimta Drug Patent Case

June 25, 2015 1:22 pm | by Stephanie Guzowski, Editor | News | Comments

Eli Lilly won a patent case in the U.K. that prohibits competitors from manufacturing a generic form of its blockbuster Alimta lung cancer drug before the patent expires in 2021. Read more...


Medical Research Not Addressing Patient, Clinician Priorities

June 25, 2015 12:37 pm | by BioMed Central | News | Comments

Research on treatments for health problems, such as diabetes, stroke and schizophrenia, is not being focused on the treatments considered most important by patients and clinicians, according to a study published in the open access journal Research Involvement and Engagement. Read more...


Scientists Pinpoint Mutations Responsible for Ineffective 2014-2015 Flu Vaccine

June 25, 2015 12:25 pm | News | Comments

Viruses like influenza have the ability to mutate over time, and given that the flu vaccines administered during the 2014-2015 season were largely ineffective at preventing the spread of the flu, it appears the virus that recently circulated had taken on mutations not accounted for when last year's vaccine was developed. Read more...


Experimental Treatment Sends Deadly Leukemia Into Remission

June 25, 2015 12:09 pm | by University of Virginia Health System | News | Comments

An experimental new treatment approach for a rare, deadly leukemia can send the disease into remission even in patients for whom the standard therapy has failed, buying them more time to have the stem cell transplant that could save their lives, a small pilot study has found. Read more...


NIH Begins Clinical Trial of New Medication for Alcohol Use Disorder

June 25, 2015 12:02 pm | by NIH | News | Comments

A clinical trial investigating a potential treatment for alcohol use disorder (AUD) was announced by the National Institute of Alcohol Abuse and Alcoholism (NIAAA). The study will assess the safety and efficacy of gabapentin enacarbil (HORIZANT) in extended-release tablets for treating moderate to severe AUD. NIAAA is part of the National Institutes of Health. Read more...


NeuroRx: First Human Trial Results Targeting Bipolar Depression, Suicidality

June 25, 2015 11:52 am | News | Comments

NeuroRx, Inc., a clinical phase pharmaceutical company, reports first-in-man efficacy data for a newly-purposed class of drugs targeted towards rapidly reducing symptoms of depression and suicidality in patients with bipolar disorder and maintaining that effect over time. Read more..


Ebola Cases Not Slowing in Guinea, Sierra Leone

June 25, 2015 9:11 am | by Youssouf Bah, Associated Press | News | Comments

Despite hopes that the deadly Ebola outbreak could soon be contained in West Africa, it shows no signs of abating in Guinea and may be flaring up once more in Sierra Leone as people are flouting rules limiting travel meant to stop it. Read more...


Research Shows Possible Way to Prevent Degenerative Eye Condition

June 25, 2015 9:07 am | by University of Oxford | News | Comments

Stargardt disease affects around 1 in 10,000 people and begins in childhood, leading to progressive loss of central vision. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.